Western blot shows Recombinant EBOV GP. PVDF membrane was probed with 2 µg/mL of Mouse Anti-Viral EBOV GP Monoclonal Antibody (Catalog # MAB9016) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # ...read more
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.
Buffer
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Reconstitution Instructions
Reconstitute at 0.5 mg/mL in sterile PBS.
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for EBOV GP Antibody (993408) [Unconjugated]
bovGP
EBOV GP
second secreted glycoprotein
small secreted glycoprotein
Spike glycoprotein
Background
The GP glycoprotein encoded by the genome of Ebola family viruses is a critical molecule for the pathogenicity of Ebolavirus hemorrhagic viruses (1, 2). It is processed into distinct forms for virus capsule or cell surface presentation or release from virus infected cells. The GP precursor protein is cleaved by furin at a multibasic site to yield a 140 kDa N-terminal fragment (GP1) and a 26 kDa C-terminal fragment (GP2) which remain disulfide linked (3). GP1 is entirely extracellular while GP2 is a transmembrane protein (4). Heterodimers of GP1-GP2 can further associate into trimers (5). GP expressed on virus infected cells can be shed by TACE mediated cleavage, liberating a disulfide linked complex of soluble GP1 and truncated GP2 (4-6). GP binds to multiple C-type lectins on target cell surfaces, including CLEC10A/MGL, DC-SIGN, and DC-SIGNR (7-9). Following internalization, GP1 is cleaved by Cathepsin B and Cathepsin L and then interacts with Niemann-Pick C1 (NPC1) in the endosomal membrane (10-12).
Yang, Z.-Y. et al. (2000) Nat. Med. 6:886.
de La Vega, M.-A. et al. (2015) Viral Immunol. 28:3.
Volchkov, V.E. et al. (1998) Proc. Natl. Acad. Sci. USA 95:5762.
Volchkov, V.E. et al. (1998) Virology 245:110.
Sanchez, A. et al. (1998) J. Virol. 72:6442.
Dolnik, O. et al. (2004) EMBO J. 23:2175.
Takada, A. et al. (2004) J. Virol. 78:2943.
Alvarez, C.P. et al. (2002) J. Virol. 76:6841.
Simmons, G. et al. (2003) Virology 305:115.
Schornberg, K. et al. (2006) J. Virol. 80:4174.
Chandran, K. et al. (2005) Science 308:1643.
Cote, M. et al. (2011) Nature 477:344.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Publications for EBOV GP Antibody (MAB9016)(2)
We have publications tested in 3 confirmed species: Human, Hamster, Primate.
We have publications tested in 1 application: Western Blot.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our EBOV GP Antibody (993408) [Unconjugated] and receive a gift card or discount.